| 2246 |
Optimal Duration of Antiplatelet Therapy Following Left Main and Bifurcation PCI |
Duk-Woo Park |
Apr. 20. 23 |
| 2245 |
Long-term Prognostic Impact of Fractional Flow Reserve After Coronary Stenting: Insights From the Internation Post-PCI FFR Extended Registry |
Bon-Kwon Koo |
Apr. 20. 23 |
| 2244 |
Optical Coherence Tomography Findings of High-risk Plaques on Coronary Computed Tomography Angiography |
Daisuke Kinoshita |
Apr. 20. 23 |
| 2243 |
Long-term Safety and Efficacy of Renal Denervation in the Global SYMPLICITY Registry Using the Symplicity Spyral Catheter |
Tzung-Dau Wang |
Apr. 20. 23 |
| 2242 |
Prediction Model for In-stent Restenosis After Carotid Artery Angioplasty and Stenting |
Sheng-Fu Liu |
Apr. 20. 23 |
| 2241 |
DM-MVD Disease: State-of-Art PCI vs. CABG |
Hoyun Kim |
Apr. 20. 23 |
| 2240 |
FATE-MAIN Trial |
Duk-Woo Park |
Apr. 20. 23 |
| 2239 |
RENOVATE Trial |
Ho Jin Kim |
Apr. 20. 23 |
| 2238 |
EPIC-CAD Trial |
Min Soo Cho |
Apr. 20. 23 |
| 2237 |
ASSURE-DES Trial |
Jung-Min Ahn |
Apr. 20. 23 |
